U.S. Attorney General Pamela Bondi announced earlier this year that opioid enforcement was one of her top enforcement priorities—signaling coming DEA audits that academic medical centers can prepare for right now. Opioid enforcement isn’t just for shady doctors and street-level dealers; it impacts large health systems with pharmacy operations too, as some academic medical centers have learned in past DEA dealings.
This webinar walks through the most common issues the DEA finds when inspecting academic medical centers, with actionable strategies and steps academic medical centers can take now to overhaul pharmacy policies and compliance processes to be ready for DEA scrutiny.
Presenters
Jonathan Porter, Partner
Who Should Attend
General counsel and other C-suite executives of academic medical centers, health systems, and pharmacies
Continuing Education Credit
This program is pending approval for Colorado, Illinois, Iowa, Kansas, Minnesota, Missouri, Nebraska, Tennessee, Texas, and Wisconsin continuing legal education credit.
Did You Miss the Webinar?
The webinar recording is available after the event date. Simply register using this on-demand link to access the recorded program.